Editorial: Targeting the endocannabinoidome in neurodegenerative disorders.
作者信息
Ishiguro Hiroki
机构信息
Department of Neuropsychiatry, Graduate School of Medicine, University of Yamanashi, Chuo, Japan.
Department of Clinical Genetics, Graduate School of Medicine, University of Yamanashi, Chuo, Japan.
出版信息
Front Aging Neurosci. 2023 Jan 4;14:1116635. doi: 10.3389/fnagi.2022.1116635. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Targeting the endocannabinoidome in neurodegenerative disorders.社论：针对神经退行性疾病中的内源性大麻素系统
Front Aging Neurosci. 2023 Jan 4;14:1116635. doi: 10.3389/fnagi.2022.1116635. eCollection 2022.
2
Differential upregulation of the cannabinoid CB₂ receptor in neurotoxic and inflammation-driven rat models of Parkinson's disease.大麻素 CB₂ 受体在神经毒性和炎症驱动的帕金森病大鼠模型中的差异上调。
Exp Neurol. 2015 Jul;269:133-41. doi: 10.1016/j.expneurol.2015.04.007. Epub 2015 Apr 18.
3
The Important Role of the Endocannabinoid System and the Endocannabinoidome in Gut Health.内源性大麻素系统和内源性大麻素组在肠道健康中的重要作用。
Altern Ther Health Med. 2019 Jun;25(S2):24-28.
4
Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others.内源性大麻素与神经退行性疾病：帕金森病、亨廷顿舞蹈症、阿尔茨海默病及其他疾病
Handb Exp Pharmacol. 2015;231:233-59. doi: 10.1007/978-3-319-20825-1_8.
5
Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target.神经退行性疾病中的大麻素受体2信号传导：从发病机制到有前景的治疗靶点
Front Neurosci. 2017 Feb 2;11:30. doi: 10.3389/fnins.2017.00030. eCollection 2017.
6
Cannabinoids and the expanded endocannabinoid system in neurological disorders.大麻素与神经系统疾病中的扩展内源性大麻素系统。
Nat Rev Neurol. 2020 Jan;16(1):9-29. doi: 10.1038/s41582-019-0284-z. Epub 2019 Dec 12.
7
Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB and CB receptors and relevance for Alzheimer's disease and levodopa-induced dyskinesia.激活小胶质细胞中内源性大麻素信号的受体异源三聚体调节。CB 和 CB 受体的作用及其与阿尔茨海默病和左旋多巴诱导运动障碍的相关性。
Brain Behav Immun. 2018 Jan;67:139-151. doi: 10.1016/j.bbi.2017.08.015. Epub 2017 Aug 24.
8
Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation-driven rat models of Parkinson's disease.大麻素 CB2 受体在环境和病毒炎症驱动的帕金森病大鼠模型中的上调。
Exp Neurol. 2016 Sep;283(Pt A):204-12. doi: 10.1016/j.expneurol.2016.06.014. Epub 2016 Jun 15.
9
The Role of Cannabinoid Type 2 Receptors in Parkinson's Disease.2型大麻素受体在帕金森病中的作用
Biomedicines. 2022 Nov 20;10(11):2986. doi: 10.3390/biomedicines10112986.
10
Cannabinoid receptor 2 selective agonists and Alzheimer's disease: An insight into the therapeutic potentials.大麻素受体2选择性激动剂与阿尔茨海默病：对治疗潜力的洞察
J Neurosci Res. 2021 Nov;99(11):2888-2905. doi: 10.1002/jnr.24933. Epub 2021 Sep 6.
引用本文的文献
1
Anandamide modulation of monocyte-derived Langerhans cells: implications for immune homeostasis and skin inflammation.大麻素内酰胺对单核细胞来源的朗格汉斯细胞的调节作用：对免疫稳态和皮肤炎症的影响。
Front Immunol. 2024 Jun 24;15:1423776. doi: 10.3389/fimmu.2024.1423776. eCollection 2024.
2
Editorial: Unravelling the role of CB2r in neuropsychiatric diseases.社论：揭示CB2r在神经精神疾病中的作用
Front Psychiatry. 2023 Mar 20;14:1171959. doi: 10.3389/fpsyt.2023.1171959. eCollection 2023.
本文引用的文献
1
The role of dopamine and endocannabinoid systems in prefrontal cortex development: Adolescence as a critical period.多巴胺和内源性大麻素系统在前额叶皮层发育中的作用：青春期是一个关键时期。
Front Neural Circuits. 2022 Nov 1;16:939235. doi: 10.3389/fncir.2022.939235. eCollection 2022.
2
An interaction between basolateral amygdala orexinergic and endocannabinoid systems in inducing anti-nociception in the rat formalin test.伏隔核外侧区食欲素能和内源性大麻素系统相互作用诱导大鼠福尔马林试验中的抗伤害作用。
Psychopharmacology (Berl). 2022 Oct;239(10):3171-3184. doi: 10.1007/s00213-022-06199-1. Epub 2022 Aug 3.
3
N-Oleoyl Glycine and Its Derivatives Attenuate the Acquisition and Expression of Cocaine-Induced Behaviors.N-油酰基甘氨酸及其衍生物可减弱可卡因诱导行为的获得和表达。
Cannabis Cannabinoid Res. 2023 Oct;8(5):812-823. doi: 10.1089/can.2022.0005. Epub 2022 May 31.
4
Amygdalar CB2 cannabinoid receptor mediates fear extinction deficits promoted by orexin-A/hypocretin-1.杏仁核 CB2 大麻素受体介导了由食欲素 A/下丘脑分泌素 1 促进的恐惧消退缺陷。
Biomed Pharmacother. 2022 May;149:112925. doi: 10.1016/j.biopha.2022.112925. Epub 2022 Apr 9.
5
Quality of Life and a Surveillant Endocannabinoid System.生活质量与监测性内源性大麻素系统
Front Neurosci. 2021 Oct 28;15:747229. doi: 10.3389/fnins.2021.747229. eCollection 2021.
6
Cannabinoid Receptor 2 Alters Social Memory and Microglial Activity in an Age-Dependent Manner.大麻素受体 2 以年龄依赖的方式改变社交记忆和小胶质细胞活性。
Molecules. 2021 Oct 2;26(19):5984. doi: 10.3390/molecules26195984.
7
The endocannabinoidome in neuropsychiatry: Opportunities and potential risks.神经精神医学中的内源性大麻素组：机遇与潜在风险。
Pharmacol Res. 2021 Aug;170:105729. doi: 10.1016/j.phrs.2021.105729. Epub 2021 Jun 11.
8
Modulation of Noradrenergic and Serotonergic Systems by Cannabinoids: Electrophysiological, Neurochemical and Behavioral Evidence.大麻素对去甲肾上腺素能和血清素能系统的调制：电生理、神经化学和行为证据。
Adv Exp Med Biol. 2021;1297:111-132. doi: 10.1007/978-3-030-61663-2_8.
9
The Expanded Endocannabinoid System/Endocannabinoidome as a Potential Target for Treating Diabetes Mellitus.扩展的内源性大麻素系统/内源性大麻素组作为治疗糖尿病的潜在靶点。
Curr Diab Rep. 2019 Nov 4;19(11):117. doi: 10.1007/s11892-019-1248-9.
10
Cannabinoid CB2 Receptor Gene and Environmental Interaction in the Development of Psychiatric Disorders.大麻素 CB2 受体基因与环境相互作用在精神障碍发病机制中的作用。
Molecules. 2018 Jul 24;23(8):1836. doi: 10.3390/molecules23081836.
Zotero 插件